dc.contributor.author | Paz-Ares, L. | |
dc.contributor.author | Reinmuth, N. | |
dc.contributor.author | Hotta, K. | |
dc.contributor.author | Trukhin, D. | |
dc.contributor.author | Poltoratskiy, A. | |
dc.contributor.author | Verderame, F. | |
dc.contributor.author | Havel, L. | |
dc.contributor.author | Bondarenko, I. | |
dc.contributor.author | Losonczy, G. | |
dc.contributor.author | Conev, N. V. | |
dc.contributor.author | Broadhurst, H. L. | |
dc.contributor.author | Dalvi, T. | |
dc.contributor.author | Jiang, H. | |
dc.contributor.author | Goldman, J. W. | |
dc.contributor.author | Chen, Y. | |
dc.contributor.author | Statsenko, G. | |
dc.contributor.author | Hochmair, M. J. | |
dc.contributor.author | ÖZGÜROĞLU, Mustafa | |
dc.contributor.author | Ji, J. H. | |
dc.contributor.author | Voitko, O. | |
dc.date.accessioned | 2021-12-10T10:36:33Z | |
dc.date.available | 2021-12-10T10:36:33Z | |
dc.identifier.citation | Paz-Ares L., Chen Y., Reinmuth N., Hotta K., Trukhin D., Statsenko G., Hochmair M. J. , ÖZGÜROĞLU M., Ji J. H. , Voitko O., et al., "Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): 3-year overall survival update from the phase III CASPIAN study", ANNALS OF ONCOLOGY, cilt.32, 2021 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_49d33218-52a1-477a-aaff-920500835799 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/170239 | |
dc.identifier.uri | https://doi.org/10.1016/j.annonc.2021.08.2142 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.title | Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): 3-year overall survival update from the phase III CASPIAN study | |
dc.type | Makale | |
dc.relation.journal | ANNALS OF ONCOLOGY | |
dc.contributor.department | Hospital Universitario 12 de Octubre , , | |
dc.identifier.volume | 32 | |
dc.contributor.firstauthorID | 2750193 | |